» Articles » PMID: 38822941

A Novel, Cassette-based Nitric Oxide Delivery System with an Advanced Feedback Control Algorithm Accurately Delivers Nitric Oxide Via the Anesthesia Machine Independent of Fresh Gas Flow Rate and Volatile Anesthetic Agent

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide (NO), a selective pulmonary vasodilator, can be delivered via conventional ICU and anesthesia machine ventilators. Anesthesia machines are designed for rebreathing of circulating gases, reducing volatile anesthetic agent quantity used. Current cylinder- and ionizing-based NO delivery technologies use breathing circuit flow to determine NO delivery and do not account for recirculated gases; therefore, they cannot accurately dose NO at FGF below patient minute ventilation (MV). A novel, cassette-based NO delivery system (GENOSYL DS, Vero Biotech Inc.) uses measured NO concentration in the breathing circuit as an input to an advanced feedback control algorithm, providing accurate NO delivery regardless of FGF and recirculation of gases. This study evaluated GENOSYL DS accuracy with different anesthesia machines, ventilation parameters, FGFs, and volatile anesthetics. GENOSYL DS was tested with GE Aisys and Dräger Fabius anesthesia machines to determine NO dose accuracy with FGF < patient MV, and with a Getinge Flow-i anesthesia machine to determine NO dose accuracy when delivering various volatile anesthetic agents. Neonatal and adult mechanical ventilation parameters and circuits were used. GENOSYL® DS maintained accurate NO delivery with all three anesthesia machines, at low FGF with recirculation of gases, and with all volatile anesthetic agents at different concentrations. Measured NO levels remained acceptable at ≤ 1 ppm with set NO dose ≤ 40 ppm. GENOSYL DS, with its advanced feedback control algorithm, is the only NO delivery system capable of accurately dosing NO with anesthesia machines with rebreathing ventilation parameters (FGF < MV) regardless of anesthetic agent.

References
1.
Singaravelu S, Barclay P . Automated control of end-tidal inhalation anaesthetic concentration using the GE Aisys Carestation™. Br J Anaesth. 2013; 110(4):561-6. DOI: 10.1093/bja/aes464. View

2.
Brattwall M, Warren-Stomberg M, Hesselvik F, Jakobsson J . Brief review: theory and practice of minimal fresh gas flow anesthesia. Can J Anaesth. 2012; 59(8):785-97. DOI: 10.1007/s12630-012-9736-2. View

3.
Wetz A, Mueller M, Walliser K, Foest C, Wand S, Brandes I . End-tidal control vs. manually controlled minimal-flow anesthesia: a prospective comparative trial. Acta Anaesthesiol Scand. 2017; 61(10):1262-1269. DOI: 10.1111/aas.12961. View

4.
Ignarro L, Buga G, Wood K, Byrns R, Chaudhuri G . Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987; 84(24):9265-9. PMC: 299734. DOI: 10.1073/pnas.84.24.9265. View

5.
Barrington K, Finer N, Pennaforte T, Altit G . Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017; 1:CD000399. PMC: 6464941. DOI: 10.1002/14651858.CD000399.pub3. View